M, B., J, C., C, R., MH, C., & G, B. (2018). Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus. Viruses, 10(11), . https://doi.org/10.3390/v10110610
Chicago Style (17th ed.) CitationM, Baz, Carbonneau J, Rhéaume C, Cavanagh MH, and Boivin G. "Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus." Viruses 10, no. 11 (2018). https://doi.org/10.3390/v10110610.
MLA (9th ed.) CitationM, Baz, et al. "Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus." Viruses, vol. 10, no. 11, 2018, https://doi.org/10.3390/v10110610.